BNP Paribas Asset Management’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
VPM
3C
VCM
6CM
BNP Paribas Asset Management's ASTH Position: Q1 2026 in Review
BNP Paribas Asset Management increased its Astrana Health (ASTH) stake by 15% in Q1 2026, buying an estimated $1.1M and bringing the position to 351,630 shares worth $8.62M. The position accounts for 0.01% of the portfolio, ranked #724.
BNP Paribas Asset Management first reported a position in ASTH in Q2 2025 and has held it in 4 quarters since. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.
- BNP Paribas Asset Management held 351,630 shares of Astrana Health worth $8.62M as of Q1 2026.
- BNP Paribas Asset Management bought 46,569 Astrana Health shares in Q1 2026, an estimated $1.1M.
- Astrana Health made up 0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #724 holding.
- BNP Paribas Asset Management first reported a position in Astrana Health in Q2 2025 and has held it in 4 quarters since.
- 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.